ProMIS Neurosciences Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PMN and other ETFs, options, and stocks.About PMN
ProMIS Neurosciences, Inc. engages in the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases. It focuses on the progression of Alzheimer's disease, amyotrophic lateral sclerosis, and Parkinson's disease.
CEONeil K. Warma
CEONeil K. Warma
Employees7
Employees7
HeadquartersToronto, Ontario
HeadquartersToronto, Ontario
Founded2004
Founded2004
Employees7
Employees7
PMN Key Statistics
Market cap19.29M
Market cap19.29M
Price-Earnings ratio-12.06
Price-Earnings ratio-12.06
Dividend yield—
Dividend yield—
Average volume35.52K
Average volume35.52K
High today$9.01
High today$9.01
Low today$8.60
Low today$8.60
Open price$8.84
Open price$8.84
Volume15.00K
Volume15.00K
52 Week high$39.75
52 Week high$39.75
52 Week low$6.27
52 Week low$6.27
Stock Snapshot
ProMIS Neurosciences Inc.(PMN) stock is priced at $8.82, giving the company a market capitalization of 19.29M. It carries a P/E multiple of -12.06.
On 2025-12-14, ProMIS Neurosciences Inc.(PMN) stock traded between a low of $8.60 and a high of $9.01. Shares are currently priced at $8.82, which is +2.6% above the low and -2.1% below the high.
The ProMIS Neurosciences Inc.(PMN)'s current trading volume is 15K, compared to an average daily volume of 35.52K.
In the last year, ProMIS Neurosciences Inc.(PMN) shares hit a 52-week high of $39.75 and a 52-week low of $6.27.
In the last year, ProMIS Neurosciences Inc.(PMN) shares hit a 52-week high of $39.75 and a 52-week low of $6.27.
People also own
Based on the portfolios of people who own PMN. This list is generated using Robinhood data, and it’s not a recommendation.